ASP-8232

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameASP-8232
Drug Alias NameASP-8232
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsDiabetic macular oedemaDiabetes Mellitus, Type 2Diabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Europe Bv
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaDiabetes Mellitus, Type 2Diabetes Mellitus +[4] 

Other Information

ATC CodeN/A
Related LinksN/A